0001354457-24-000308.txt : 20240425
0001354457-24-000308.hdr.sgml : 20240425
20240425091120
ACCESSION NUMBER: 0001354457-24-000308
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20240425
DATE AS OF CHANGE: 20240425
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ProSomnus, Inc.
CENTRAL INDEX KEY: 0001934064
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 882978216
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41567
BUSINESS ADDRESS:
STREET 1: 5675 GIBRALTAR DR
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: 844-537-5337
MAIL ADDRESS:
STREET 1: 5675 GIBRALTAR DR
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: LAAA Merger Corp.
DATE OF NAME CHANGE: 20220615
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
ORGANIZATION NAME:
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001934064
ProSomnus, Inc.
001-41567
5675 Gibraltar Drive
Pleasanton
CA
CALIFORNIA
94588
925-353-7904
Common stock and warrant
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2024-04-25
EX-99.25
2
osadelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, April 25, 2024,
ProSomnus, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of ProSomnus, Inc., effective at the
opening of the trading session on May 6, 2024.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5450(b)(2)(A).
The Company was notified of the Staff determination on February 13,
2024. On February 16, 2024, the Company exercised its right to appeal
the Staff determination to the Listing Qualifications Hearings Panel
(Panel) pursuant to Listing Rule 5815.
The Company received an additional delist determination on March 19,
2024, pursuant to Listing Rule 5450(b)(2&3)(C).
A hearing on the matter was scheduled for April 16, 2024. On April 16,
2024, the Company witdrew its appeal. The Company securities were
suspended on April 18, 2024. The Staff determination to delist the
Company securities became final on April 18, 2024.